Advertisement

March 4, 2020

SymphonyAI Group Acquires TeraRecon

March 4, 2020—SymphonyAI Group, an operating group of business-to-business artificial intelligence (AI) companies, announced the acquisition of TeraRecon, a provider of tools for advanced visualization and AI software solutions for radiologists and other highly specialized physicians needing to quickly visualize and extract critical clinical data from medical images.

According to the announcement, SymphonyAI Group will invest in infrastructure and key initiatives to produce new advancements and offerings through TeraRecon’s engineering and product teams. TeraRecon will operate as an independent portfolio company in the SymphonyAI Group. TeraRecon technologies will complement the precision oncology offerings of portfolio company Concerto HealthAI. TeraRecon products include the iNtuition, EnvoyAI, and the Northstar AI Results Explorer.

TeraRecon will continue to focus on expanding its open platform for advanced visualization and AI-driven solutions. In addition to its solutions in radiology, cardiology, and vascular surgery, the company will accelerate the use of AI in other clinical specialties, including neurology and oncology.

Advertisement


March 4, 2020

CryoLife’s E-vita Open Neo Hybrid Stent Graft Approved in Europe

March 4, 2020

NULL